Associate Director, Marketing

Join us in helping patients with rare diseases. At Egetis Therapeutics we challenge the status quo for the benefit of those in need. We offer an open, positive and supportive culture where everyone can be their best. Through trust, we work seamlessly across functions. As an employee you are empowered and encouraged to have an entrepreneurial spirit, enjoying an organization with conscious and efficient decision‑making and we take pride in our collaborative working environment!

In February 2025, the European Commission approved Egetis’ Emcitate® (tiratricol) as the first and only treatment of peripheral thyrotoxicosis in patients with monocarboxylate transporter 8 (MCT8) deficiency (Allan‑Herndon‑Dudley Syndrome). In January 2026, Egetis completed the U.S. rolling NDA submission to the FDA for Emcitate® (tiratricol) for treatment of patients with MCT8 deficiency.

As a committed, courageous and collaborative organization, we are seeking to grow our team to drive success both in the pre‑launch and post launch phases of our anticipated U.S. approval.

For more information, please visit our website at  or follow us on Linked In and Facebook.

The Associate Director (AD) Marketing will be the primary U.S. marketing leader and a key member of the U.S. commercial team, responsible for building and executing the U.S. launch and growth strategy for Egetis’s first U.S. launch. This highly visible, hands‑on role will establish core U.S. Marketing competences, with a focus on digital capabilities to establish impactful omnichannel strategies, while leading end‑to‑end planning and execution of brand strategies and tactics for both HCPs and patients.

This individual will join a small, nimble and energetic organization that requires excellent communication, organization and collaboration skills. Reporting to the Head of Commercial (U.S.) this individual will have the ability to make meaningful impact on the growth of the organization.

• Own the U.S. brand strategy and positioning for Egetis product, grounded in deep understanding of disease area, customer segments, and the treatment landscape.
• Lead the annual U.S. brand planning process including objectives, target segments, key messages, and tactical roadmap across HCP, patient/caregiver, and advocacy audiences.

• Support the U.S. prelaunch and launch planning efforts, ensuring cross‑functional alignment on milestones, critical path, and organizational readiness.
• Assist in regularly assessing commercial key performance indicators to identify gaps and drive course corrections.
• Develop and execute integrated promotional tools and campaigns across digital platforms, in‑person tools, P2P, congresses and patient facing initiatives.
• Drive unbranded disease education to increase disease awareness and support earlier suspicion and diagnosis.

• Develop innovative, insight driven HCP engagement strategies to expand disease understanding, its diagnostic journey, and Egetis product value proposition.
• Lead congress and society/association strategy and execution (booths, symposia, materials, satellite events, digital extensions).
• Partner with Patient Services and external advocacy organizations to gain patient/caregiver insights and assist in the development of patient specific programs

• High engagement and collaboration with the Key Account Manager (Sales) team to ensure consistent and optimized delivery of branded messaging and programs
• Lead the development and optimization offield tools (detail aids, leave behinds, digital assets, training content) to support effective HCP engagement.
• Gather and synthesize field and market insights to refine strategy, inform new tactical approaches, and identify competitive dynamics.

• Monitor key marketing, sales, and market metrics to identify trends, gaps, and opportunities, translating findings into clear actions.
• Lead the execution of market research such as message testing, patient journey work and HCP qualitative research.
• Support…